Incremental costs of treating tetanus with intrathecal antitetanus immunoglobulin

Tropical Medicine and International Health

Volumn 18, Issue 5, 2013, Pages 555-563

  Miranda Filho, Demócrito B ^a   Ximenes, Ricardo A A ^a,b   Siqueira Filha, Noêmia T ^c   Santos, Andreia C ^d  

^a UNIVERSIDADE DE PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c Instituto de Avaliação de Tecnologias em Saúde   (Brazil)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Costs; Immunoglobulin; Incremental costs; Intrathecal injection; Tetanus

Indexed keywords

ANTIBIOTIC AGENT; TETANUS ANTIBODY;

ANTIBIOTICS; COST-BENEFIT ANALYSIS; DECISION MAKING; DISEASE TREATMENT; RESPIRATORY DISEASE; STEROID; TETANUS;

ANTIBIOTIC THERAPY; ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; COST CONTROL; DISEASE SEVERITY; DRUG COST; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; TETANUS;

ADOLESCENT; CHILD; COST SAVINGS; COSTS AND COST ANALYSIS; DRUG THERAPY, COMBINATION; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SPINAL; OXYGEN INHALATION THERAPY; SEVERITY OF ILLNESS INDEX; TETANUS; TETANUS ANTITOXIN; TREATMENT OUTCOME;

BRAZIL; PERNAMBUCO; RECIFE;

EID: 84876084441     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12091     Document Type: Article

References (12)

1. Abrutyn E & Berlin JA (1991) Intrathecal therapy in tetanus, a meta-analysis. JAMA 266, 2262-2267.
2. Agarwal M, Thomas K, Peter JV, Jeyaseelan L & Cherian AM (1998) A randomised double-blind sham controlled study of intrathecal human anti-tetanus immunoglobulin in the management of tetanus. The National Medical Journal of India 11, 209-212.
3. Ahmad A, Qaisar I, Naeem M, Mazhar AU & Ashfaq M (2011) Intrathecal anti-tetanus human immunoglobulin in the treatment of neonatal tetanus. Journal of the College of Physicians and Surgeons Pakistan 21, 539-541.
4. Attygalle D & Rodrigo N (2004) New trends in the management of tetanus. Expert Review of Anti-Infective Therapy 2, 73-84.
5. Brauner JS, Vieira SR & Bleck TP (2002) Changes in severe accidental tetanus mortality in the ICU during two decades in Brazil. Journal of Intensive Care Medicine 28, 930-935.
6. Drummond MF, Sculper MJ, Torrance GW, O'Brien BJ & Stoddart GL (2005) Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, New York.
7. Gouveia PAC, Silva CEF, Miranda-Filho DB, Bernardino SN, Escarião AG & Ximenes RAA (2009) Mortality trend due to accidental tetanus from 1981 to 2004 in Pernambuco and analysis of the impact on intensive care unit attendance. Revista da Sociedade Brasileira de Medicina Tropical 42, 54-57.
8. Griffiths UK, Santos AC, Nundy N, Jacoby E & Matthias D (2011) Incremental costs of introducing jet injection technology for delivery of routine childhood vaccinations: comparative analysis from Brazil, India, and South Africa. Vaccine 29, 969-975.
9. Kabura L, Ilibagiza D, Menten J & Van den Ende J (2006) Intrathecal vs. intramuscular administration of human antitetanus immunoglobulin or equine tetanus antitoxin in the treatment of tetanus: a meta-analysis. Tropical Medicine & International Health 11, 1075-1081.
10. Miranda Filho DB, Ximenes RAA, Barone AA, Vaz VL, Vieira AG & Albuquerque VMG (2004) Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route. BMJ 328, 615.
11. Miranda-Filho DB, Ximenes RAA, Barone AA, Vaz VL, Vieira AG & Albuquerque VMG (2006) Clinical classification of tetanus patients. Brazilian Journal of Medical and Biological Research 39, 1329-1337.
12. Thwaites CL & Farrar JJ (2003) Preventing and treating tetanus. The challenge continues in the face of neglect and lack of research. BMJ 326, 117-118.